ALGRX 4975 in the Treatment of Patients With Morton's Neuroma
Clinical trial NCT00130962 · COMPLETED
Trial details
- NCT number
- NCT00130962
- Sponsor
- AlgoRx Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.